XBIOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
XBIOTECH INC. (XBIT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-13
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-06-30 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-09-30 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-06-30 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-13 | 0.00% 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-13 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-12 | 0.00% 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-13 | 0.00% 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-13 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-12 | 0.00% 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-13 | 0.00% 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-18 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-13 | 0.00% 10-Q · filed 2024-11-13 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 0.00% 10-K · filed 2022-03-15 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-09 | 0.00% 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-09 | 0.00% 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-15 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-09 | 0.00% 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-09 | 0.00% 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | 0.00% 10-K · filed 2022-03-15 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2020-11-09 | 0.00% 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-10 | 0.00% 10-Q · filed 2020-08-10 | ||
| 2018-12-31 | 0.00% 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |